Iwona Gorczyca−Michta
YOU?
Author Swipe
View article: Integrated Care in Patients with Atrial Fibrillation and Optimal Medical Treatment for Heart Failure: Results from the Heart failuRe ObsErvational Study (HEROES)
Integrated Care in Patients with Atrial Fibrillation and Optimal Medical Treatment for Heart Failure: Results from the Heart failuRe ObsErvational Study (HEROES) Open
Background: Heart failure (HF) and atrial fibrillation (AF) often coexist, and this has a major impact on prognosis. Only a limited amount of data is available on the effect of integrated strategies to improve prognosis in patients with HF…
View article: Impact of acute pancreatitis on the outcomes of cholecystectomy. An observational multicenter retrospective study
Impact of acute pancreatitis on the outcomes of cholecystectomy. An observational multicenter retrospective study Open
Purpose Gallstones are the most common cause of acute pancreatitis (AP), which usually necessitate hospitalization. Although cholecystectomy is required to prevent recurrent episodes, no clear guidelines have been established yet regarding…
View article: Sex-related differences in the prevalence, clinical characteristics, and comorbidities of metabolic dysfunction-associated steatotic liver disease
Sex-related differences in the prevalence, clinical characteristics, and comorbidities of metabolic dysfunction-associated steatotic liver disease Open
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disease in patients with fatty liver and cardiometabolic risk factors. Its prevalence and severity are higher in men than in women of …
View article: More Than Just a Complication: Post-ERCP Pancreatitis and Its Clinical Determinants in over 800 Procedures
More Than Just a Complication: Post-ERCP Pancreatitis and Its Clinical Determinants in over 800 Procedures Open
Background: Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) remains the most frequent and clinically significant complication of ERCP, with a multifactorial etiology involving patient- and procedure-related risk fact…
View article: Sex Differences in Patients with MASLD and Their Association with Cardiometabolic Risk Factors: Insights from the Polish Gallstone Surgery Registry
Sex Differences in Patients with MASLD and Their Association with Cardiometabolic Risk Factors: Insights from the Polish Gallstone Surgery Registry Open
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined by the presence of hepatic steatosis and at least one cardiometabolic risk factor. Differences in the incidence of MASLD between men and women are prim…
View article: Risk factors for prolonged hospitalization in acute decompensated heart failure from the HEROES study
Risk factors for prolonged hospitalization in acute decompensated heart failure from the HEROES study Open
This study, part of the HEROES project (HEart failure Risk factOrs and patiEnt Stratification), aimed to identify clinical, laboratory, functional, and treatment-related factors associated with hospitalization duration (above and below 8 d…
View article: Practical aspects of antiplatelet therapy individualization among patients undergoing PCI for ACS and CCS. The joint expert opinion of the Working Group on Cardiovascular Pharmacotherapy and the Association of Cardiovascular Interventions of the PCS
Practical aspects of antiplatelet therapy individualization among patients undergoing PCI for ACS and CCS. The joint expert opinion of the Working Group on Cardiovascular Pharmacotherapy and the Association of Cardiovascular Interventions of the PCS Open
Dual antiplatelet therapy remains the cornerstone of medical therapy among patients undergoing percutaneous coronary interventions for acute coronary syndrome or chronic coronary syndromes. Dual antiplatelet therapy is instrumental in redu…
View article: Sex Differences in Patients with MASLD and Their Association with Cardiometabolic Risk Factors: Insights from the Polish Gallstone Surgery Registry
Sex Differences in Patients with MASLD and Their Association with Cardiometabolic Risk Factors: Insights from the Polish Gallstone Surgery Registry Open
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined by the presence of hepatic steatosis and at least one the cardiometabolic risk factors. Differences in the incidence of MASLD between men and women are…
View article: How does the direct oral anticoagulant dosage affect long-term prognosis in patients with atrial fibrillation and heart failure? Results from the HEart failuRe ObsErvational Study (HEROES)
How does the direct oral anticoagulant dosage affect long-term prognosis in patients with atrial fibrillation and heart failure? Results from the HEart failuRe ObsErvational Study (HEROES) Open
In the present study, a significant percentage of patients with AF and HF received non-recommended doses of DOACs. Factors that predisposed to the prescription of non-recommended DOAC doses included those that increased the risk of bleedin…
View article: Atrial fibrillation in patients with heart failure with reduced, mildly reduced, and preserved ejection fraction: A report from the HEart failuRe ObsErvational Study (HEROES)
Atrial fibrillation in patients with heart failure with reduced, mildly reduced, and preserved ejection fraction: A report from the HEart failuRe ObsErvational Study (HEROES) Open
In the population with HF, the AF incidence is similar in the HFrEF, HFmrEF, and HFpEF groups. It is associated with similar clinical characteristics in HF subtypes.
View article: Impact of Various Oral Hypoglycemic Agents on Hepatic Steatosis Reduction in MASLD and Type 2 Diabetes: Exploring the Bidirectional Relationship. A Narrative Review
Impact of Various Oral Hypoglycemic Agents on Hepatic Steatosis Reduction in MASLD and Type 2 Diabetes: Exploring the Bidirectional Relationship. A Narrative Review Open
OBJECTIVE: This review aims to explore the impact of various classes of oral hypoglycemic agents on hepatic steatosis reduction and liver functions in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and type …
View article: Clinical characteristics and risk factors of metabolic dysfunction-associated steatotic liver disease in lean patients: results of the Polish Gallstone Surgery Registry
Clinical characteristics and risk factors of metabolic dysfunction-associated steatotic liver disease in lean patients: results of the Polish Gallstone Surgery Registry Open
Lean MASLD is not a rare form of the disease, and in the lean MASLD group there are patients with a high rate of metabolic abnormalities which may significantly increase cardiovascular risk and the risk of MASLD progression.
View article: Immunopathology of Corneal Allograft Rejection and Donor-Specific Antibodies (DSAs) as Immunological Predictors of Corneal Transplant Failure
Immunopathology of Corneal Allograft Rejection and Donor-Specific Antibodies (DSAs) as Immunological Predictors of Corneal Transplant Failure Open
Despite tremendous developments in the field of laboratory testing in transplantation, the rules of eligibility for corneal transplantation still do not include typing of human leukocyte antigens (HLAs) in the donor and recipient or detect…
View article: A 22-G or a 25-G Needle: Which One to Use in the Diagnostics of Solid Pancreatic Lesions? A Systematic Review and Meta-Analysis
A 22-G or a 25-G Needle: Which One to Use in the Diagnostics of Solid Pancreatic Lesions? A Systematic Review and Meta-Analysis Open
With the 12th highest incidence and a common late diagnostic at advanced stages, neoadjuvant therapies for pancreatic cancer are important, but they require a confirmed diagnosis. Being a diagnostic standard, the clarification of the clini…
View article: Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF)
Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF) Open
OACs were used much less frequently in the group with a high HAS-BLED score than in the group with a low score. Independent predictors of nonuse of OACs were creatinine levels, a history of gastrointestinal bleeding, and malignant neoplasm…
View article: From NAFLD to MASLD – a new approach for the definition of fatty liver disease associated with metabolic dysfunction
From NAFLD to MASLD – a new approach for the definition of fatty liver disease associated with metabolic dysfunction Open
Metabolic dysfunction-associated steatotic liver disease (MASLD) is common, affecting a quarter of the population. The pathogenesis of this disease is multifactorial and has been well known for years. After 40 years of using the binding de…
View article: Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre Open
Atrial fibrillation (AF) is associated with an increased risk of stroke. Therefore, patients with AF require appropriate management and anticoagulant therapy. To balance therapy risks and benefits, oral anticoagulants (OAC) treatment shoul…
View article: Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society
Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society Open
Heart failure (HF) remains one of the most common causes of hospitalization and mortality among Polish patients. The position of the Section of Cardiovascular Pharmacotherapy presents the currently applicable options for pharmacological tr…
View article: Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society
Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society Open
The diagnosis of metabolic associated fatty liver disease (MAFLD) is significant for patients' prognosis, as the disease accelerates the development of cardiovascular complications and, on the other hand, cardiometabolic conditions are ris…
View article: Long-Term Outcomes after Stroke in Patients with Atrial Fibrillation: A Single Center Study
Long-Term Outcomes after Stroke in Patients with Atrial Fibrillation: A Single Center Study Open
Atrial fibrillation (AF) is known to be a significant risk factor for poor prognosis after stroke. In this study, we compared differences in long-term outcomes after ischemic stroke among patients with AF and sinus rhythm (SR). We identifi…
View article: Risk factors of ischaemic stroke in patients with atrial fibrillation
Risk factors of ischaemic stroke in patients with atrial fibrillation Open
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Tracz J, Gorczyca-Głowacka I, Wałek P, Rosołowska A, Wożakowska-Kapłon B. Risk factors of ischaemic stroke in patients with atrial fibrillation. Medical Stud…
View article: Secondary prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation – clinical practice in relation to guidelines
Secondary prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation – clinical practice in relation to guidelines Open
AMA Bielecka B, Gorczyca-Głowacka I, Ciba-Stemplewska A, Wożakowska-Kapłon B. Secondary prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation – clinical practice in relation to guidelines. Medical Stud…
View article: The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society
The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society Open
Type 2 diabetes mellitus (T2DM) is a metabolic disease resulting from many pathophysiological processes leading to chronic hyperglycemia, and its incidence in societies is constantly increasing.For many years, it has also been recognized a…
View article: Rules for using reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society
Rules for using reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society Open
A C TNon-vitamin K antagonist oral anticoagulants (NOACs) are commonly used in stroke prevention in patients with atrial fibrillation.Although the rules for using standard and reduced doses of NOACs are defined, there is a significant perc…